Clinical trials
Phase 4 Ischemic Attack, Transient trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 2 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alberta | 2 |
| Emory University | 1 |
| Istituto Auxologico Italiano | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| Peking Union Medical College Hospital | 1 |
| Prof. dr. Nathalie van der Velde | 1 |
| Seoul National University Hospital | 1 |
| Sichuan Provincial People's Hospital | 1 |
| UMC Utrecht | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Attack, Transient | 12 |
| Stroke | 7 |
| Ischemic Stroke | 4 |
| Cardiovascular Diseases | 2 |
| Cerebrovascular Disorders | 2 |
| Antiphospholipid Syndrome | 1 |
| Arteriosclerosis | 1 |
| Atherosclerosis | 1 |
| Brain Ischemia | 1 |
| Dementia | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.